Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Nerviano Medical Sciences patents IDH inhibitors

June 1, 2021

Nanjing Ruijie Pharma divulges ACC inhibitors

June 1, 2021

AbbVie initiates first-in-human study of ABBV-623 and ABBV-992

June 1, 2021

Bacteriophage delivery of TNF-alpha gene therapy suppresses chondrosarcoma tumors in vivo

June 1, 2021

Disulfiram/copper gluconate studied in phase I for treatment-refractory multiple myeloma

May 31, 2021

RNF6 and SF3B2 are novel therapeutic targets in colorectal cancer

May 31, 2021

BPRCX-807 demonstrates promising activity in models of HCC

May 31, 2021

Nanjing Sanhome Pharmaceutical synthesizes PTPN11 inhibitors

May 31, 2021

Guangzhou Henovcom Bioscience patents ENPP2 inhibitors

May 31, 2021

Phase I/II study of RVU-120 in solid tumors approved in Poland

May 31, 2021

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...